packageMolnupiravir
molnupiravir
Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).
Information
Molnupiravir is an antiviral drug that was developed for the treatment of COVID-19 infection. Its marketing authorisation application in the European Union was withdrawn, and it remains investigational rather than an approved medicine.
Summary written by glm-5.3-flash from Wikidata Q96376832 and the WHO ATC classification and the EMA medicines list; not checked by a person.
| name: | molnupiravir |
| ATC codes: | J05AB18 |
| DrugBank: | DB15661 |
| PubChem CID: | 145996610 |
| Wikidata: | Q96376832 |
| formula: | C13H19N3O7 |
| molar mass: | 329.309 g/mol (PubChem CID 145996610) |
| logP: | -0.8 (Drugs.Common 25.09, not verified) |
Metabolites
NHCDN4Hydroxycytidine | NHC (β-D-N4-hydroxycytidine) (NHC) | 259.218 g/mol (pubchem) |
Parameters
| Type | Name | Default | Description |
|---|---|---|---|
| String | name (from PartialSubstance) | "" | INN / common name |
| String[:] | atcCodes (from PartialSubstance) | fill("", 0) | all WHO ATC codes of the drug |
| String | drugbankId (from PartialSubstance) | "" | e.g. DB00758 |
| String | pubchemCid (from PartialSubstance) | "" | PubChem compound id |
| String | chebiId (from PartialSubstance) | "" | ChEBI id (number) |
| String | wikidataId (from PartialSubstance) | "" | e.g. Q410238 |
| String | formula (from PartialSubstance) | "" | molecular formula |
| Modelica.Units.SI.MolarMass | M (from PartialSubstance) | 0 | molar mass; 0 = unknown |
| Real | logP (from PartialSubstance) | Modelica.Constants.inf | octanol-water partition coefficient (log10); inf = unknown |
Contents
| Name | Description |
|---|---|
| metabolite: NHC (β-D-N4-hydroxycytidine) |